Similarly, as important fibrotic markers, α-SMA, TGF-β, COL1A1, and desmin expression was also inhibited by KXRG treatment, thus inhibiting hepatic fibrosis. The gene discussed is ACTA1; the disease is Hepatic fibrosis.